About Us

We have assembled a team of leading cell therapy scientists and drug developers. 

Team Members

Sarah Hein, PhD

CEO, Co-Founder

Max Mamonkin, PhD

CSO, Co-Founder

Malcolm Brenner, MD, Phd

Co-founder and Chair Scientific Advisory Board

Alice Bexon

Alice Bexon, MD

Acting Chief Medical Officer

Victoria Lake

Victoria Lake, RAC

Head of Regulatory

Doris Sanchez

Doris Sanchez

Head of Clinical Development and Product StRategy

Bambi Grilley, RAC

Regulatory Strategy and Translation

Federica Giordano, PhD

Associate Director of Operations

Aaron Vernon, MS

Strategic Advisor Technical Operations

Board Members

Sarah Hein, PhD

CEO, Co-Founder

Max Mamonkin, PhD

CSO, Co-Founder

Thomas Luby, PhD

TMC Ventures

Joseph Petrosino, PhD

Baylor College of Medicine

Peter Olagunju, MBA

Independent Director

Steven Lehmann, MBA

Portal Innovations
(observer)

Omar Haneef, MBA

Small Ventures
(observer)

Advisory Members

Malcolm Brenner, MD, Phd​

Co-founder and Chair Scientific Advisory Board

Helen Heslop, MD

Director Cell and Gene Therapy Center, Baylor College of Medicine

LaQuisa Hill, MD

Assistant Professor Hematology, Baylor College of Medicine

Steve Horwitz, MD

Oncologist, T-cell Lymphoma, Memorial Sloan Kettering Cancer Center

Swaminathan P. Iyer, MD

Professor Department of Lymphoma / Myeloma, MD Anderson Cancer Center

Investors & Partners

Investors & Partners

TMC Venture logo
Portal Innovations logo
Small Ventures logo
Baylor College of Medicine Logo